• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?

0
  • by alexperjescuadmin
  • in Cardiovascular
  • — 5 Nov, 2007
TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?
AudioMedica News
TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?
TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?
00:00 /
RSS Feed
Share
Link
Embed
Gordon Tomaselli
Gordon Tomaselli
Daniel Jones
Daniel Jones

REFERENCE: Late Breaking Clinical Trials 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
GORDON TOMASELLI, Johns Hopkins University, Baltimore
COMMENT: DANIEL JONES, President, American Heart Association, University of Mississippi, Jackson

A potential new option for patients with acute coronary syndromes receiving coronary intervention has emerged following a report on the comparison of prasugrel, a new anti-platelet agent, with clopidogrel. Elliott Antman from Brigham and Women’s Hospital in Boston gave the American Heart Association his findings and recommendations about when and in which patients prasugrel might be favored. Gordon Tomaselli discussed the findings with Sarah Maxwell.

[audio:https://www.audiomedica.com/podcasting/cardio/071104TomaselliJonesPODCAST.mp3]
Share

Tags: aboutacuteagentcardiovascularclopidogrelcommentscoronaryfindingsheartjournalNewspatientpodcastpodcastingreportreportssyndrometrial

You may also like...

  • Heart Failure Drug Prevents Renal Damage? Heart Failure Drug Prevents Renal Damage? 13 Apr, 2008
  • Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006 Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006 15 Nov, 2006
  • Eight Blood Pressure Genes Bring Promise For Drug Design Eight Blood Pressure Genes Bring Promise For Drug Design 29 Jun, 2009
  • Andreas Gille Direct infusions of HDL to prevent re-infarction in patients with acute coronary syndromes 16 Nov, 2012

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Eptifibatide After PCI: Brief Infusion Is Just As Good
  • Next story Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • ALK—Targeted Lung Cancer Drugs Benefited Real…
    • Which Tasks Most Influence Pediatric PT…
    • Genomic-led AML Clinical Decision Making Within Seven Days
  • Home
  • Cardiovascular
  • TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.